![Mathurin Fumery on Twitter: Mathurin Fumery on Twitter:](https://pbs.twimg.com/media/D1NovXhXgAEIkHe.jpg:large)
Mathurin Fumery on Twitter: "Efficacy and Safety of ustekinumab optmisation in Crohn's disease #ECCO19 plenary session https://t.co/9NBT4Fb1GQ" / Twitter
![Biomedicines | Free Full-Text | The Revival of Surgery in Crohn's Disease—Early Intestinal Resection as a Reasonable Alternative in Localized Ileitis Biomedicines | Free Full-Text | The Revival of Surgery in Crohn's Disease—Early Intestinal Resection as a Reasonable Alternative in Localized Ileitis](https://www.mdpi.com/biomedicines/biomedicines-09-01317/article_deploy/html/images/biomedicines-09-01317-g001.png)
Biomedicines | Free Full-Text | The Revival of Surgery in Crohn's Disease—Early Intestinal Resection as a Reasonable Alternative in Localized Ileitis
Dominik Bettenworth on Twitter: "Fully agree, @fgomollon. Highly recommended & free read: 'Is Crohn's Disease a Rightly Used Eponym?' by #SimonTravis & #vanHootegem https://t.co/jhbmsQwNhP Including Stricture drawning by Dr. Lesniowski in 1903 !! @
![COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/11/front_matter-JCC-Journal-pdf.jpg)
COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease
![PDF) Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies PDF) Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies](https://i1.rgstatic.net/publication/333445914_Efficacy_and_Safety_of_Adalimumab_by_Disease_Duration_Analysis_of_Pooled_Data_From_Crohn's_Disease_Studies/links/5cf1cd6c4585153c3daa27a3/largepreview.png)
PDF) Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies
![Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut](https://gut.bmj.com/content/gutjnl/70/6/1044/F1.large.jpg)
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut
![14th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology 14th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/e63342e3c9fd510184d2343b4232c16550758458/MASTER_ECCO%2719%20Web%20banner_150x100%20%28002%29.jpg)